본문으로 건너뛰기

논문 검색

검색 결과: 17,849SQL fulltext  ·  📄 CSV ↓  ·  📖 OA 100%

📖 출처 필터 (다중 토글 · 이 페이지 결과만)
📖 이 페이지: 20/20편 (100%) 무료 전문 가능 · 무료전문만 보기 →
  • Trends and projections of Burkitt Lymphoma burden (1990-2036): an analysis based on the global burden of disease study 2021.
    Hematology (Amsterdam, Netherlands) 2026 Zhou Y 📖 OA PDF 🆕 신규 PMID: 41862409 ↗

    [OBJECTIVES] The aim of this study was to assess the burden of Burkitt lymphoma (BL) at the global, regional, and national levels from 1990-2021 and to project trends over the next 15 years. [METHODS] Data from the 2021 Global Burden of Di…

    FULLTEXT: Development
  • Development and validation of a nomogram for the overall survival of patients with locally advanced prostate cancer treated with radiotherapy and surgery.
    The aging male : the official journal of the International Society for the Study of the Aging Male 2026 Zhang B 📖 OA PDF 🆕 신규 PMID: 41503827 ↗

    [BACKGROUND] Prostate cancer (PC) is a common malignancy in older adults. We aimed to construct a nomogram for the overall survival (OS) of elderly patients with locally advanced PC who received radiotherapy and surgery. [METHODS] Clinical…

    FULLTEXT: Development
  • Development and validation of machine learning prognostic models for overall survival in non-surgical prostate cancer patients with bone metastases.
    The aging male : the official journal of the International Society for the Study of the Aging Male 2026 Yang Q 📖 OA PDF 🆕 신규 PMID: 41839858 ↗

    [OBJECTIVE] To construct and interpret a machine learning model for predicting overall survival in nonsurgical prostate cancer with bone metastases (PCBM). [METHODS] Data from 3,378 SEER database patients were utilized to develop machine l…

    FULLTEXT: Development
  • Novel bacterium sp. M3 promotes colorectal tumorigenesis via the production of the carcinogen styrene.
    Gut microbes 2026 Zeng Y 🟢 PMC 🆕 신규 PMID: 41693466 ↗

    [BACKGROUND] The bacterial marker 'm3' shows promise for the non-invasive diagnosis of colorectal cancer (CRC) and adenomas. However, the m3-harboring bacterium (M3) had not been successfully cultured. [OBJECTIVE] This study aims to elucid…

    FULLTEXT: Development
  • secreted factors drive epithelial-mesenchymal transition (EMT) through gingipains and an HS-mediated bacterial defense system.
    Gut microbes 2026 Kazelnik M 🟢 PMC 🆕 신규 PMID: 41873832 ↗

    Dysbiosis of the gut microbiota is strongly associated with a wide range of pathologies, including various types of cancer. Porphyromonas gingivalis ), an oral bacterium, is implicated in the development of colorectal cancer (CRC), and alth…

    FULLTEXT: Development
  • Multi-platform analysis of the tumor immune microenvironment associated with breast cancer subtypes.
    Oncoimmunology 2026 Torland LA 🟢 PMC 🆕 신규 PMID: 41530924 ↗

    Breast cancer is genetically and histologically heterogenous, and is influenced by a variety of factors, including the tumor microenvironment (TME). The PAM50 subtypes; Luminal A, Luminal B, Normal-like, Basal-like and Her2-enriched, are as…

    FULLTEXT: Development
  • Steroid receptor coactivator 3-deficient regulatory T cells eradicate multiple solid tumors in syngeneic mouse models.
    Oncoimmunology 2026 Sung N 🟢 PMC 🆕 신규 PMID: 41772940 ↗

    Steroid receptor coactivator 3 (SRC-3) is highly expressed in regulatory T cells (Tregs) and is important for their immunosuppressive activity. Recently, we demonstrated that disrupting SRC-3 expression in Tregs eliminates triple-negative b…

    FULLTEXT: Development
  • Early local immune activation following intra-operative radiotherapy in human breast tissue.
    Oncoimmunology 2026 Tiefenthaller A 📖 OA PDF 🆕 신규 PMID: 41943280 ↗

    The local immune effects of cancer radiotherapy remain poorly characterized in humans due to limited access to irradiated tissue. Mechanistic insights largely derive from preclinical models employing tumor-intact, neoadjuvant-like settings.…

    FULLTEXT: Development
  • Nanotherapeutics for enhanced treatments for ovarian cancer: a comprehensive minireview.
    Drug delivery 2026 Xu X 🟢 PMC 🆕 신규 PMID: 41423932 ↗

    As one of the most lethal gynecological malignancies, ovarian cancer (OC) significantly impacts the health and quality of life of women globally. Currently, surgical intervention and chemotherapy remain the primary clinical treatment modali…

    FULLTEXT: Development
  • Polymersome-based nanomedicine for combined cancer therapy.
    Drug delivery 2026 Mohammadi Zonouz A 🟢 PMC 🆕 신규 PMID: 41427517 ↗

    Cancer is a complex disease characterized by uncontrolled cell growth and spread, often resulting in metastasis. The use of combination therapy, which involves the simultaneous application of two or more treatment methods, aims to enhance e…

    FULLTEXT: Development
  • Trial Watch - bispecific T cell engagers and higher-order multispecific immunotherapeutics.
    Oncoimmunology 2026 Xue E 🟢 PMC 🆕 신규 PMID: 41700001 ↗

    Over the past decades, cancer immunotherapy has evolved into clinical practice, with bispecific T cell engagers (TCEs) and other higher-order multispecific immunotherapeutics emerging as approaches for precision immune modulation. These eng…

    FULLTEXT: Development
  • Extracellular payload release from non-internalizing antibody-drug conjugates: mechanisms and linker technologies.
    Drug delivery 2026 Feng C 🟢 PMC 🆕 신규 PMID: 41866709 ↗

    Antibody‒drug conjugates (ADCs) have taken on a significant role in precision oncology. These molecules, referred to as 'biological missiles', can deliver cytotoxic drugs directly to cancer cells. Traditional ADCs rely on endocytosis and in…

    FULLTEXT: Development
  • Development of a novel immune infiltration-based gene signature to predict prognosis and immunotherapy response of a novel anti-PD-L1/TGF-β bifunctional fusion protein in recurrent cervical cancer.
    Human vaccines & immunotherapeutics 2026 Mao Y 📖 Unpaywall unknown 🆕 신규 PMID: 41866914 ↗

    The hypothesis-generating case study aimed at identifying those who are sensitive to anti-PD-L1 and TGF-β bifunctional fusion proteins and exploring potential mechanisms in the treatment of recurrent cervical cancer. We report that recurren…

    FULLTEXT: Development
  • Enhanced magnetic hyperthermia using anti-PD-L1 antibody-conjugated magnetoliposomes in a murine subcutaneous bladder cancer model.
    International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2026 Gonda M 📖 Unpaywall CC BY 🆕 신규 PMID: 41887926 ↗

    [BACKGROUND/OBJECTIVES] Bladder cancer (BC) often arises in an immunosuppressive tumor microenvironment that limits responses to immune checkpoint inhibitors. Magnetic hyperthermia therapy (MHT) can induce immunogenic cell death, but its va…

    FULLTEXT: Development
  • LILRB2 inhibition by blocking antibody ES009 reprograms immunosuppressive myeloid cells and enhances T-cell-mediated tumor immunity.
    Human vaccines & immunotherapeutics 2026 Niu X 📖 Unpaywall unknown 🆕 신규 PMID: 42007674 ↗

    The inhibitory receptor leukocyte immunoglobulin-like receptor B2 (LILRB2), expressed on myeloid cells like monocytes and tumor-resident myeloid cells, sustains an immunosuppressive tumor microenvironment and promotes tumor progression. Pha…

    FULLTEXT: Development
  • A real-world study evaluating drug tolerability and health care resource use with acalabrutinib vs ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Journal of medical economics 2026 Dranitsaris G 📖 OA PDF 🆕 신규 PMID: 41454883 ↗

    [BACKGROUND AND AIM] Bruton tyrosine kinase inhibitors (BTKis) are the standard of care for patients with relapsed/refractory (R/R) chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). Ibrutinib and acalabrutinib are two commo…

    FULLTEXT: Development
  • Whole transcriptome sequencing reveals differences in the pathogenesis of myelodysplastic syndromes and acute myeloid leukemia.
    Hematology (Amsterdam, Netherlands) 2026 Zhou M 📖 OA PDF 🆕 신규 PMID: 41769973 ↗

    [OBJECTIVES] Myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) are closely related hematologic malignancies. However, the transcriptomic distinctions between them are not fully elucidated. This study aimed to identify transcri…

    FULLTEXT: Development
  • TNS1 and TNS4 play a potential role in development of pancreatic ductal adenocarcinoma but not TNS2 and TNS3.
    Cell adhesion & migration 2026 Świsłocka N 🟢 PMC 🆕 신규 PMID: 41923376 ↗

    Tensins are a family of adhesion proteins that play a role in constructing the cytoskeleton, as well as in intracellular and extracellular communication. Their expression was evaluated in 22 pancreatic cancer patients using the immunohistoc…

    FULLTEXT: Development
  • Migrasomes: new communicators between cells.
    Cell cycle (Georgetown, Tex.) 2026 He J 🟢 PMC 🆕 신규 PMID: 41949167 ↗

    Migrasomes are a recently discovered class of organelles, typically generated at the intersections and tips of retraction fibers (RFs) in migrating cells. These monolayer vesicular structures encapsulate a variety of bioactive molecules and…

    FULLTEXT: Development
  • The prevalence and predictors of previous prostate cancer screening among men attending primary healthcare centers in Riyadh, Saudi Arabia.
    Annals of medicine 2026 Alshahrani S 🟢 PMC 🆕 신규 PMID: 41830420 ↗ 단면연구

    [BACKGROUND] Early detection through screening is crucial for improving treatment outcomes and reducing disease burden. . This study investigates the predictors of previous prostate cancer screening among Saudi men attending primary healthc…

    FULLTEXT: Development